Home non‐invasive ventilation (NIV) is being increasingly employed to treat chronic hypercapnic respiratory failure (CHcRF). However, there is little data on compliance with home NIV. Sixty‐five patients, aged 72.6 ± 9.4 years, who were using home NIV were administered a questionnaire on symptomatology and adverse effects associated with home NIV. Mean daily use of home NIV was 7.3 ± 2.9 h/day and the median percentage of days on which home NIV was used for ≥4 h/day was 96.7%.© 2012 The Authors. Respirology © 2012 Asian Pacific Society of Respirology

Source: Respirology
Read Full Article